alfuzosin
CHEBI:CHEBI_51141
Chemical Information
- Molecular Formula
- C19H27N5O4
- Molecular Mass
- 389.44898
- Charge
- 0
- SMILES
- COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C1CCCO1
- InChI
- InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)
- InChIKey
- WNMJYKCGWZFFKR-UHFFFAOYSA-N
Alternative Names
- alfuzosin
- alfuzosina
- alfuzosine
- alfuzosinum
- N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide
Drug Classification
-
monocarboxylic acid amideView Class →
CHEBI:29347
-
quinazolinesView Class →
CHEBI:38530
-
tetrahydrofuranolView Class →
CHEBI:47017
-
t241211
-
t241979
-
t242205
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 17300
- oboInOwl#hasDbXref
- Wikipedia:Alfuzosin
- core#notation
- CHEBI:51141
Additional References
Wikipedia:Alfuzosin
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 17300
- oboInOwl#hasDbXref
- Wikipedia:Alfuzosin
- oboInOwl#id
- CHEBI:51141
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- dosage_form
- TABLET, FILM COATED, EXTENDED RELEASE
- labeler_name
- Concordia Pharmaceuticals Inc.
- marketing_start_date
- 20050118
- generic_name
- Alfuzosin HCl
- brand_name
- Uroxatral
- brand_name_base
- Uroxatral
- product_ndc
- 47335-956
- application_number
- ANDA090284
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_35674
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- route
- ORAL
- spl_id
- 70258299-7c72-4a10-8d0c-4a5e3b2a0fc8
- package_ndc
- 47335-956-88
- package_description
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-88)
- core#notation
- CHEBI:51141
- rxcui
- 861134
- active_ingredient_strength
- 50 kg/50kg
- package_marketing_start_date
- 30-AUG-12
- manufacturer_name
- Concordia Pharmaceuticals Inc.
- pharm_class
- alpha-Adrenergic Blocker [EPC]
- active_ingredient_name
- N-(3-((4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)METHYLAMINO)PROPYL)FURAN-2-CARBOXAMIDE
- unii
- 75046A1XTN
- spl_set_id
- d2af616e-673a-4fdd-ace8-db2d0f154604
- upc
- 0347335956818
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_47
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect27730
- owl#annotatedSource
- t242094
- owl#someValuesFrom
- t3005833